Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

CREBBP Loss Cooperates with BCL2 Over-Expression to Promote Lymphoma in Mice

Blood (2016) 128 (22): 458.

https://doi.org/10.1182/blood.V128.22.458.458

Published: 2016

Journal Articles

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 2686.

https://doi.org/10.1182/blood.V128.22.2686.2686

Published: 2016

Journal Articles

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Roberto A. Ferro, MD, Vijaya R. Bhatt, MD, Martin Bast, BS, Lynette Smith, MS, R. Gregory Bociek, MD, Matthew A. Lunning, DO, Philip J Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD

Blood (2015) 126 (23): 1504.

https://doi.org/10.1182/blood.V126.23.1504.1504

Published: 2015

Journal Articles

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Anamarija M. Perry, MD, Diebold Jacques, MD, Bharat N. Nathwani, MD, Kenneth Angus Maclennan, MD, H Konrad Müller-Hermelink, Eugene Boilesen, Martin Bast, BS, James O. Armitage, MD, Dennis D. Weisenburger, MD

Blood (2015) 126 (23): 1484.

https://doi.org/10.1182/blood.V126.23.1484.1484

Published: 2015

Journal Articles

Clinicopathologic Features, Management and Outcomes of Blastoid Variant (BV) of Mantle Cell Lymphoma (MCL): A Nebraska Lymphoma Study Group (NLSG) Experience

Vijaya R. Bhatt, MBBS, Fausto R. Loberiza, MD MS, James O. Armitage, MD, Timothy C. Greiner, MS, MD, Martin Bast, BS, Matthew A. Lunning, DO, Philip Bierman, MD, Julie M. Vose, MD MBA, R. Gregory Bociek, MD MSc.

Blood (2014) 124 (21): 2971.

https://doi.org/10.1182/blood.V124.21.2971.2971

Published: 2014

Journal Articles

Utility Of Pre-Chemotherapy Echocardiograms

John Allen Steuter, MD/Cardiology Fellow, Philip Bierman, MD, R. Gregory Bociek, MD, Martin Bast, BS

Blood (2013) 122 (21): 2950.

https://doi.org/10.1182/blood.V122.21.2950.2950

Published: 2013

Journal Articles

Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy

Matthew A. Lunning, DO, Jocelyn C. Maragulia, BS, Anita Kumar, MD, Martin Bast, BS, Philip Bierman, MD, R. Gregory Bociek, MD, Julie M Vose, MD, MBA, James O. Armitage, MD, Steven M. Horwitz, MD, Andrew D Zelenetz, MD, PhD

Blood (2013) 122 (21): 3017.

https://doi.org/10.1182/blood.V122.21.3017.3017

Published: 2013

Journal Articles

Lack Of Clinical Benefit For Routine Surveillance Imaging For Diffuse Large B-Cell Lymphoma In First Complete Remission

Julie M Vose, MD, MBA, Ravi Pingali, MD, Nina Wagner-Johnson, MD, Fausto R. Loberiza, Jr., MD, MS, Timothy S. Fenske, MD, Sarah Jewell, Martin Bast, BS, Nancy L. Bartlett, MD, James O. Armitage, MD

Blood (2013) 122 (21): 4303.

https://doi.org/10.1182/blood.V122.21.4303.4303

Published: 2013

Journal Articles

Outcome of Adolescent & Young Adult (AYA) Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Jill C. Beck, MD, Martin Bast, BS, Deborah A. Perry, MD, Lynette M. Smith, MS, Dennis D. Weisenburger, MD

Blood (2012) 120 (21): 1568.

https://doi.org/10.1182/blood.V120.21.1568.1568

Published: 2012

Journal Articles

Primary Breast Diffuse Large B Cell Lymphoma: A Distinct Clinical Entity

Matthew P Salzberg, Jocelyn C Maragulia, Oliver W. Press, MD, PhD, Thomas M Habermann, MD, Julie M Vose, MD, MBA, Martin Bast, BS, Ranjana H. Advani, MD, Andrew M. Evens, DO, MSc, Nahida Islam, MD, John P. Leonard, MD, Peter Martin, MD, Peter J Hosein, MD, Andrew D Zelenetz, MD, PhD, Izidore S Lossos, MD

Blood (2012) 120 (21): 1618.

https://doi.org/10.1182/blood.V120.21.1618.1618

Published: 2012

Journal Articles

Lymphoma with Features Intermediate Between DLBCL and Burkitt Lymphoma: Better Outcome with Intensive Chemotherapy Regimens

David G Crockett, MD, Anamarija M. Perry, MD, James O. Armitage, MD, Dennis D Weisenburger, MD, Martin Bast, BS, Fausto R. Loberiza, Jr., MD, MS

Blood (2011) 118 (21): 2710.

https://doi.org/10.1182/blood.V118.21.2710.2710

Published: 2011

Journal Articles

The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)

Kerry Joanne Savage, MD, MSc, Hilary M O'Leary, MBBChBAO, MRCPI, MRCPath, Joseph M Connors, MD, Mukesh Chhanabhai, MD, Belinda Campbell, MD, Laurie H Sehn, MD, MPH, Randy D. Gascoyne, MD, R. Gregory Bociek, MD, James O. Armitage, MD, Dennis D. Weisenburger, MD, Julie M. Vose, Martin Bast, BS, Philip Bierman, MD

Blood (2010) 116 (21): 4129.

https://doi.org/10.1182/blood.V116.21.4129.4129

Published: 2010

Journal Articles

Rituximab Added to Aggressive Chemotherapy Improves the Outcome of Patients with Follicular Lymphoma, Grade 3 and Results In Survival Comparable to Diffuse Large B-Cell Lymphoma.

Philip J. Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Fausto R. Loberiza, Jr., MD, MS, Martin Bast, BS, James O. Armitage, MD

Blood (2010) 116 (21): 2810.

https://doi.org/10.1182/blood.V116.21.2810.2810

Published: 2010

Journal Articles

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Julie M. Vose, MD, John C. Chan, MD, Philip J. Bierman, MD, Alejandro Arevalo, MD, Fausto Loberiza, MD, Kai Fu, MD, Dennis Weisenburger, MD, Robert G. Bociek, MD, Martin Bast, BS, James O. Armitage, MD

Blood (2007) 110 (11): 3430.

https://doi.org/10.1182/blood.V110.11.3430.3430

Published: 2007

Journal Articles

Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.

Philip Bierman, MD, Julie M. Vose, MD, R. Gregory Bociek, MD, Fausto Loberiza, MD, Martin Bast, BS, Dennis D. Weisenburger, MD, James Olen Armitage, MD

Blood (2007) 110 (11): 3451.

https://doi.org/10.1182/blood.V110.11.3451.3451

Published: 2007

Journal Articles

Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma.

Philip Bierman, MD, Fausto Loberiza, MD, Bhavana Dave, PhD, Warren Sanger, PhD, R. Gregory Bociek, MD, Martin Bast, BS, Julie M. Vose, MD, James Olen Armitage, MD, Dennis Weisenburger, MD

Blood (2006) 108 (11): 2030.

https://doi.org/10.1182/blood.V108.11.2030.2030

Published: 2006

NARROW

CREBBP Loss Cooperates with BCL2 Over-Expression to Promote Lymphoma in Mice

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

Tolerability and Efficacy of Treatments in Elderly Patients with Hodgkin Lymphoma: A Report from the Nebraska Lymphoma Study Group

Classification of Non-Hodgkin Lymphoma in Seven Geographic Regions Around the World: Review of 4539 Cases from the International Non-Hodgkin Lymphoma Classification Project

Clinicopathologic Features, Management and Outcomes of Blastoid Variant (BV) of Mantle Cell Lymphoma (MCL): A Nebraska Lymphoma Study Group (NLSG) Experience

Utility Of Pre-Chemotherapy Echocardiograms

Cell Of Origin Does Not Affect Outcomes In Early Stage Non-Bulky Diffuse Large B-Cell Lymphoma Treated With Short-Course Combined Modality Therapy

Lack Of Clinical Benefit For Routine Surveillance Imaging For Diffuse Large B-Cell Lymphoma In First Complete Remission

Outcome of Adolescent & Young Adult (AYA) Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Primary Breast Diffuse Large B Cell Lymphoma: A Distinct Clinical Entity

Lymphoma with Features Intermediate Between DLBCL and Burkitt Lymphoma: Better Outcome with Intensive Chemotherapy Regimens

The Prognosis of Limited Stage Peripheral T-Cell Lymphoma (PTCL): A Population-Based Analysis and Comparison to Diffuse Large B-Cell Lymphoma (DLBCL)

Rituximab Added to Aggressive Chemotherapy Improves the Outcome of Patients with Follicular Lymphoma, Grade 3 and Results In Survival Comparable to Diffuse Large B-Cell Lymphoma.

Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.

Outcome of Limited-Stage Peripheral T-Cell Lymphoma: Results from the Nebraska Lymphoma Study Group.

Significance of c-myc Rearrangements in Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only